NIH Record - National Institutes of Health
Prostate Cancer: BRCA2 deficiency

September 13, 2024

  • How to LAUNCH a Global Health Research Career

    The Fogarty International Center brought trainees from across the globe to NIH's Bethesda campus for its annual, week-long orientation program.
  • Professor Expounds on the How and Why of Sleep

    Previous sleep studies pointed to a single sleep center in the brain. Recent research instead reveals a larger, distributed and interconnected network of sleep neurons across the brain and beyond. A neurobiology professor from UC-Berkeley expounds on this research.
  • Former NBA Player Turned Psychologist Offers Team-Building Advice

    Professor John Amaechi is no stranger to working on a team. He is an organizational psychologist, the founder of APS Intelligence, a New York Times best-selling author, an officer of the Order of the British Empire and a retired NBA player. Recently, he gave NIH’ers tips on establishing good leadership and cohesive teams.
Prostate Cancer: BRCA2 deficiency

On the Cover

NHGRI researchers have identified a specific genomic signature of some aggressive prostate tumors. The finding focuses on BRCA2 mutations, which are associated with breast and ovarian cancer, but also increase men’s risk for prostate cancer. Both men and women can inherit a faulty BRCA2 gene. When working properly, the BRCA2 gene helps stop cells from becoming cancerous by producing proteins that fix damage to DNA.

ERNESTO DEL AGUILA III/NHGRI

The NIH Record

The NIH Record, founded in 1949, is the biweekly newsletter for employees of the National Institutes of Health.

Published 25 times each year, it comes out on payday Fridays.

Assistant Editor: Eric Bock
Eric.Bock@nih.gov (link sends e-mail)

Staff Writer: Amber Snyder
Amber.Snyder@nih.gov (link sends e-mail)